Literature DB >> 19871272

THE LS-ANTIGEN OF VACCINIA : IV. CHEMICAL ANALYSIS OF LS AND THE EFFECT OF CHYMOTRYPSIN ON LS.

J E Smadel1, C L Hoagland, T Shedlovsky.   

Abstract

Pure LS-antigen of vaccinia contains 15.8 per cent N and 50.6 per cent C. These analytical data together with the absence of lipids, phosphorus, nucleic acid, and glucosamine in preparations of the antigen confirm the protein nature of the substance. The action of proteolytic enzymes on LS offers further confirmation of the protein character of the antigen. Both the L- and S-activities of the antigen are destroyed by digestion with papain. The effects of crystalline chymotrypsin on LS-antigen are particularly interesting for, under proper conditions, this enzyme destroys the serological activity of the S-portion of the molecule without affecting the L-portion. This newly prepared degradation product of LS, called LS'', contains the same amount of N as the native substance but unlike LS, it forms needle-shaped crystalloids.

Entities:  

Year:  1943        PMID: 19871272      PMCID: PMC2135326          DOI: 10.1084/jem.77.2.165

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  THE LS-ANTIGEN OF VACCINIA : III. PHYSICAL-CHEMICAL PROPERTIES OF LS-ANTIGEN AND SOME OF ITS DEGRADATION PRODUCTS.

Authors:  T Shedlovsky; A Rothen; J E Smadel
Journal:  J Exp Med       Date:  1943-02-01       Impact factor: 14.307

2.  CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA : III. THE EFFECT OF PURIFIED ENZYMES ON ELEMENTARY BODIES OF VACCINIA.

Authors:  C L Hoagland; S M Ward; J E Smadel; T M Rivers
Journal:  J Exp Med       Date:  1940-11-30       Impact factor: 14.307

3.  IMMUNOLOGICAL STUDIES OF A HEAT-STABLE SUBSTANCE ISOLATED FROM TISSUES INFECTED WITH VACCINE VIRUS.

Authors:  R F Parker
Journal:  J Exp Med       Date:  1938-02-28       Impact factor: 14.307

4.  IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : VI. ISOLATION OF A HEAT-STABLE, SEROLOGICALLY ACTIVE SUBSTANCE FROM TISSUES INFECTED WITH VACCINE VIRUS.

Authors:  R F Parker; T M Rivers
Journal:  J Exp Med       Date:  1937-01-31       Impact factor: 14.307

5.  THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY.

Authors:  T Shedlovsky; J E Smadel
Journal:  J Exp Med       Date:  1942-01-31       Impact factor: 14.307

6.  STUDIES ON THE SOLUBLE PRECIPITABLE SUBSTANCES OF VACCINIA : II. THE SOLUBLE PRECIPITABLE SUBSTANCES OF DERMAL VACCINE.

Authors:  J Craigie; F O Wishart
Journal:  J Exp Med       Date:  1936-10-31       Impact factor: 14.307

7.  CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA : I. CERTAIN BASIC ANALYSES AND OBSERVATIONS ON LIPID COMPONENTS OF THE VIRUS.

Authors:  C L Hoagland; J E Smadel; T M Rivers
Journal:  J Exp Med       Date:  1940-05-31       Impact factor: 14.307

  7 in total
  2 in total

1.  THE LS-ANTIGEN OF VACCINIA : III. PHYSICAL-CHEMICAL PROPERTIES OF LS-ANTIGEN AND SOME OF ITS DEGRADATION PRODUCTS.

Authors:  T Shedlovsky; A Rothen; J E Smadel
Journal:  J Exp Med       Date:  1943-02-01       Impact factor: 14.307

2.  Disruption of influenza virus; properties of degradation products of the virus particle.

Authors:  D A TYRRELL; F L HORSFALL
Journal:  J Exp Med       Date:  1954-04-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.